These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

300 related articles for article (PubMed ID: 28393295)

  • 1. Elevated Galectin-9 Suppresses Th1 Effector Function and Induces Apoptosis of Activated CD4
    Yang S; Wang J; Chen F; Liu G; Weng Z; Chen J
    Inflammation; 2017 Jun; 40(3):1062-1071. PubMed ID: 28393295
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Tim-3/galectin-9 pathway involves in the homeostasis of hepatic Tregs in a mouse model of concanavalin A-induced hepatitis.
    Ju Y; Shang X; Liu Z; Zhang J; Li Y; Shen Y; Liu Y; Liu C; Liu B; Xu L; Wang Y; Zhang B; Zou J
    Mol Immunol; 2014 Mar; 58(1):85-91. PubMed ID: 24333756
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of human T cell immunoglobulin domain and mucin-3 (TIM-3) and TIM-3 ligands in peripheral blood from patients with systemic lupus erythematosus.
    Jiao Q; Qian Q; Zhao Z; Fang F; Hu X; An J; Wu J; Liu C
    Arch Dermatol Res; 2016 Oct; 308(8):553-61. PubMed ID: 27394439
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tim-3-expressing macrophages are functionally suppressed and expanded in oral squamous cell carcinoma due to virus-induced Gal-9 expression.
    Dong J; Cheng L; Zhao M; Pan X; Feng Z; Wang D
    Tumour Biol; 2017 May; 39(5):1010428317701651. PubMed ID: 28466780
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of human TIM-3 and its correlation with disease activity in rheumatoid arthritis.
    Lee J; Oh JM; Hwang JW; Ahn JK; Bae EK; Won J; Koh EM; Cha HS
    Scand J Rheumatol; 2011; 40(5):334-40. PubMed ID: 21446887
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Underexpression of TIM-3 and blunted galectin-9-induced apoptosis of CD4+ T cells in rheumatoid arthritis.
    Lee J; Park EJ; Noh JW; Hwang JW; Bae EK; Ahn JK; Koh EM; Cha HS
    Inflammation; 2012 Apr; 35(2):633-7. PubMed ID: 21717191
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activated Galectin-9/Tim3 promotes Treg and suppresses Th1 effector function in chronic lymphocytic leukemia.
    Pang N; Alimu X; Chen R; Muhashi M; Ma J; Chen G; Zhao F; Wang L; Qu J; Ding J
    FASEB J; 2021 Jul; 35(7):e21556. PubMed ID: 34137463
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Galectin-9 ameliorates anti-GBM glomerulonephritis by inhibiting Th1 and Th17 immune responses in mice.
    Zhang Q; Luan H; Wang L; He F; Zhou H; Xu X; Li X; Xu Q; Niki T; Hirashima M; Xu G; Lv Y; Yuan J
    Am J Physiol Renal Physiol; 2014 Apr; 306(8):F822-32. PubMed ID: 24477688
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Upregulation of the Tim-3/Gal-9 pathway and correlation with the development of preeclampsia.
    Hao H; He M; Li J; Zhou Y; Dang J; Li F; Yang M; Deng D
    Eur J Obstet Gynecol Reprod Biol; 2015 Nov; 194():85-91. PubMed ID: 26342682
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antigen-independent induction of Tim-3 expression on human T cells by the common γ-chain cytokines IL-2, IL-7, IL-15, and IL-21 is associated with proliferation and is dependent on the phosphoinositide 3-kinase pathway.
    Mujib S; Jones RB; Lo C; Aidarus N; Clayton K; Sakhdari A; Benko E; Kovacs C; Ostrowski MA
    J Immunol; 2012 Apr; 188(8):3745-56. PubMed ID: 22422881
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recipient T cell TIM-3 and hepatocyte galectin-9 signalling protects mouse liver transplants against ischemia-reperfusion injury.
    Liu Y; Ji H; Zhang Y; Shen X; Gao F; He X; Li GA; Busuttil RW; Kuchroo VK; Kupiec-Weglinski JW
    J Hepatol; 2015 Mar; 62(3):563-72. PubMed ID: 25450716
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Galectin-9 contributes to the pathogenesis of atopic dermatitis
    Su W; Zhang J; Yang S; Tang M; Shen Y; Liu C; Ji J; Maurer M; Jiao Q
    Front Immunol; 2022; 13():952338. PubMed ID: 35967337
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A role for the TIM-3/GAL-9/BAT3 pathway in determining the clinical phenotype of multiple sclerosis.
    Saresella M; Piancone F; Marventano I; La Rosa F; Tortorella P; Caputo D; Rovaris M; Clerici M
    FASEB J; 2014 Nov; 28(11):5000-9. PubMed ID: 25091272
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of Tim-3/Galectin-9 pathway in T-cell function and prognosis of patients with human papilloma virus-associated cervical carcinoma.
    Chen Z; Dong D; Zhu Y; Pang N; Ding J
    FASEB J; 2021 Mar; 35(3):e21401. PubMed ID: 33559190
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modulatory effect of Tim-3/Galectin-9 axis on T-cell-mediated immunity in pulmonary tuberculosis.
    Kang J; Wei ZF; Li MX; Wang JH
    J Biosci; 2020; 45():. PubMed ID: 32345786
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interaction between Galectin-9/TIM-3 pathway and follicular helper CD4
    Zhuo Y; Zhang YF; Wu HJ; Qin L; Wang YP; Liu AM; Wang XH
    Biomed Pharmacother; 2017 Oct; 94():386-393. PubMed ID: 28772217
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Galectin-9 and T cell immunoglobulin mucin-3 pathway is a therapeutic target for type 1 diabetes.
    Kanzaki M; Wada J; Sugiyama K; Nakatsuka A; Teshigawara S; Murakami K; Inoue K; Terami T; Katayama A; Eguchi J; Akiba H; Yagita H; Makino H
    Endocrinology; 2012 Feb; 153(2):612-20. PubMed ID: 22186414
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tim-3/galectin-9 signaling pathway mediates T-cell dysfunction and predicts poor prognosis in patients with hepatitis B virus-associated hepatocellular carcinoma.
    Li H; Wu K; Tao K; Chen L; Zheng Q; Lu X; Liu J; Shi L; Liu C; Wang G; Zou W
    Hepatology; 2012 Oct; 56(4):1342-51. PubMed ID: 22505239
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Galectin-9 increases Tim-3+ dendritic cells and CD8+ T cells and enhances antitumor immunity via galectin-9-Tim-3 interactions.
    Nagahara K; Arikawa T; Oomizu S; Kontani K; Nobumoto A; Tateno H; Watanabe K; Niki T; Katoh S; Miyake M; Nagahata S; Hirabayashi J; Kuchroo VK; Yamauchi A; Hirashima M
    J Immunol; 2008 Dec; 181(11):7660-9. PubMed ID: 19017954
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Galectin-9 binding to Tim-3 renders activated human CD4+ T cells less susceptible to HIV-1 infection.
    Elahi S; Niki T; Hirashima M; Horton H
    Blood; 2012 May; 119(18):4192-204. PubMed ID: 22438246
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.